Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could transform treatment for millions struggling with device therapies.

Sleep apnea is a serious condition, causing breathing to stop and start several times during sleep. The most common form of the condition is obstructive sleep apnea, where the throat narrows, blocking ...

Sleep apnea is a common sleep disorder that causes frequent breathing pauses while you sleep. Treating sleep apnea aims to reduce breathing interruptions (called apneas) and improve your sleep. Sleep ...

About half of people who are prescribed the gold-standard treatment stop using it. The treatment, a continuous positive airway pressure, or CPAP, device keeps the airway open, but many find it loud ...

TYPE OF SLEEP APNEA. RESTLESS SLEEP AT NIGHT CAN AFFECT YOUR ENTIRE DAY. THERE ARE MANY REASONS WHY YOU MAY NOT BE GETTING ENOUGH SHUT EYE RANGING FROM INSOMNIA, STRESS, OR EVEN SLEEP APNEA. SLEEP ...

Eli Lilly’s weight loss injection tirzepatide — the ingredient inside its wildly popular drugs Mounjaro and Zepbound — could also help treat sleep apnea, according to research published Friday, a ...

If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...

Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...